Hookipa Pharma Inc. Stock News

Analysts have been eager to weigh in on the Healthcare sector with new ratings on SAGE Therapeutics ( SAGE – Research Report ) and Hookipa Pharma ( HOOK – Research Report ). SAGE Therapeutics (SAG

NEW YORK and VIENNA, Austria, March 19, 2020 -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious.

NEW YORK, NY / ACCESSWIRE / March 19, 2020 / HOOKIPA Pharma, Inc. (NASDAQ:HOOK) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 19, 2020 at 8:0

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ...

The biopharma space bled along with the rest of the market and COVID-19 levered biotechs weren't spared either.Biogen Inc (NASDAQ: BIIB) was in the news for all wrong reasons, as an employee conferenc

The biopharma space bled along with the rest of the market and COVID-19 levered biotechs weren't spared either. Biogen Inc (NASDAQ: BIIB) was in the news for all wrong...

NEW YORK and VIENNA, Austria, March 10, 2020 -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious.

NEW YORK and VIENNA, Austria, Feb. 18, 2020 -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious.

Zubac once spent a day training with Kareem Abdul-Jabbar, and now he wants more.

HOOKIPA Pharma and Viking Therapeutics could catch first at some point this year. Here's why.

A Colorado lawmaker has introduced a bill seeking to prevent employers from firing staff for using marijuana for recreational purposes when off the clock.

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

NEW YORK and VIENNA, Austria, Jan. 06, 2020 -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious.

HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today

Is HOOKIPA Pharma Inc. (NASDAQ:HOOK) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top invest